Cargando…

Disparities in opioid treatment access and retention among women based on pregnancy status from 2006 to 2017

BACKGROUND: The purpose of this study is to assess differences in wait time and retention in opioid use disorder (OUD) treatment among a sample of pregnant and non-pregnant women from low-income urban communities in Los Angeles, California. METHODS: Data were collected in 9 waves consisting of conse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khachikian, Tenie, Amaro, Hortensia, Guerrero, Erick, Kong, Yinfei, Marsh, Jeanne C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Full Length Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975179/ https://www.ncbi.nlm.nih.gov/pubmed/35369381 http://dx.doi.org/10.1016/j.dadr.2022.100030

Ejemplares similares

Gender disparities in opioid treatment progress in methadone versus counseling
por: Guerrero, Erick, et al.
Publicado: (2021)

Disparities in expected driving time to opioid treatment and treatment completion: findings from an exploratory study
por: Alibrahim, Abdullah, et al.
Publicado: (2022)

Correction to: Disparities in expected driving time to opioid treatment and treatment completion: findings from an exploratory study
por: Alibrahim, Abdullah, et al.
Publicado: (2022)

Understanding the role of financial capacity in the delivery of opioid use disorder treatment
por: Guerrero, Erick G., et al.
Publicado: (2023)

Identifying gender differences in risk profiles and in opioid treatment outcomes in Los Angeles County
por: Amaro, Hortensia, et al.
Publicado: (2023)

Exploring Gender and Ethnoracial Differences and Trends in Methamphetamine Treatment
por: Guerrero, Erick G, et al.
Publicado: (2023)

Workforce Diversity and disparities in wait time and retention among opioid treatment programs
por: Guerrero, Erick G., et al.
Publicado: (2022)

Using machine learning to advance disparities research: Subgroup analyses of access to opioid treatment
por: Kong, Yinfei, et al.
Publicado: (2021)

Co-occurring psychiatric disorders and disparities in buprenorphine utilization in opioid use disorder: An analysis of insurance claims
por: Xu, Kevin Y, et al.
Publicado: (2023)

Critical access medication for opioid use disorder (MOUD) treatment facilities in the continental United States
por: Pollack, Harold A., et al.
Publicado: (2022)

Association of chronic non-cancer pain status and buprenorphine treatment retention among individuals with opioid use disorder: Results from electronic health record data
por: John, William S., et al.
Publicado: (2022)

Medicaid expansion and opioid supply policies to address the opioid overdose crisis
por: Shakya, Shishir, et al.
Publicado: (2022)

Epidemiology of patients with asthma in Korea: Analysis of the NHISS database 2006–2015
por: Kim, Jung-Hyun, et al.
Publicado: (2023)

Prescription stimulant use during long-term opioid therapy and risk for opioid use disorder
por: Scherrer, Jeffrey F., et al.
Publicado: (2022)

Qualitative exploration of public health vending machines in young adults who misuse opioids: A promising strategy to increase naloxone access in a high risk underserved population
por: Wagner, Nicole M., et al.
Publicado: (2022)

Global disparities in availability of epinephrine auto-injectors
por: Tanno, Luciana Kase, et al.
Publicado: (2023)

Quality of life during a randomized trial of a therapeutic-workplace intervention for opioid use disorder: Web-based mobile assessments reveal effects of drug abstinence and access to paid work
por: Bertz, Jeremiah W., et al.
Publicado: (2021)

Parenting and childcare responsibilities, harm reduction service engagement, and opioid overdose among women and men who use illicit opioids in New York City
por: Scheidell, Joy D, et al.
Publicado: (2022)

Opioid distribution trends (2006–2017) in the US Territories
por: Cabrera, Fedor F., et al.
Publicado: (2019)

Hospitalist perspectives on buprenorphine treatment for inpatients with opioid use disorder
por: Reed, Megan K, et al.
Publicado: (2022)

Under-representation of key demographic groups in opioid use disorder trials
por: Rudolph, Kara E., et al.
Publicado: (2022)

COVID-19 impact on opioid overdose after jail release in Massachusetts
por: Friedmann, Peter D., et al.
Publicado: (2023)

Time-lagged association between counseling and/or 12-Step attendance with subsequent opioid use in a secondary analysis from a randomized, clinical trial of medications for opioid use disorder
por: Hefner, Kathryn, et al.
Publicado: (2022)

Differential expression of NPAS4 in the dorsolateral prefrontal cortex following opioid overdose
por: Sosnowski, David W., et al.
Publicado: (2022)

Barriers to and Disparities in Access to Health Care Among Adults Aged ≥18 Years with Epilepsy — United States, 2015 and 2017
por: Tian, Niu, et al.
Publicado: (2022)

Racial disparities in COVID-19 associated pulmonary embolism: A multicenter cohort study
por: Metra, Brandon, et al.
Publicado: (2021)

Contextualizing prescription opioid misuse and heroin use within dimensional models of drug involvement
por: Dash, Genevieve F., et al.
Publicado: (2022)

Negative attitudes about medications for opioid use disorder among criminal legal staff
por: Moore, Kelly E., et al.
Publicado: (2022)

The policy landscape for naloxone distribution in four states highly impacted by fatal opioid overdoses
por: Bohler, Robert M., et al.
Publicado: (2022)

Implementation opportunities for scaling up methadone maintenance treatment in Kyrgyzstan: Methadone dosage and retention on treatment over two years
por: Ivasiy, Roman, et al.
Publicado: (2022)

Bone tumor-homing nanotherapeutics for prolonged retention in tumor microenvironment and facilitated apoptotic process via mevalonate pathway inhibition
por: Kang, Nae-Won, et al.
Publicado: (2023)

Dynamic changes in prescription opioids from 2006 to 2017 in Texas
por: Ighodaro, Ebuwa O., et al.
Publicado: (2019)

Signal of increased opioid overdose during COVID-19 from emergency medical services data
por: Slavova, Svetla, et al.
Publicado: (2020)

Opioid treatment program prescribing of methadone with community pharmacy dispensing: Pilot study of feasibility and acceptability
por: Brooner, Robert K., et al.
Publicado: (2022)

The association between medication for opioid use disorder and employment outcomes in the U.S.: The relevance of race and ethnicity
por: Hoang, Bai Linh, et al.
Publicado: (2022)

Psychiatric comorbidities and their treatment predict buprenorphine continuation among postpartum people with opioid use disorder
por: Shadowen, Hannah, et al.
Publicado: (2022)

Inverse association of anti-inflammatory prescription fills and suicide-related mortality in young adults: Evidence from a nationwide study of Swedish regions, 2006–2021
por: Andersson, Peter, et al.
Publicado: (2023)

Residential treatment and medication treatment for opioid use disorder: The role of state Medicaid innovations in advancing the field
por: O'Brien, Peggy L., et al.
Publicado: (2022)

Specific polysubstance use patterns predict relapse among patients entering opioid use disorder treatment
por: Pan, Yue, et al.
Publicado: (2022)

Sustainment of contingency management within opioid treatment programs: COVID-related barriers and innovative workflow adaptations
por: Becker, Sara J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_roh0kepnn92fgcu8ojrre9l23f